GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Electromed ELMD · USD

Health Care · US listing · 🇺🇸 United States

Compare

27.06

-0.40%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Electromed

From its filings with the US Securities and Exchange Commission

SEC filings

Electromed is based in New Prague, Minnesota and is incorporated in Minnesota. Its shares trade on NYSE under the ticker ELMD. The SEC classifies its business as electromedical & electrotherapeutic apparatus. In the fiscal year to 30 June 2026, it reported revenue of $73.8m and net income of $11.3m. At that date it held total assets of $66.3m and shareholders' equity of $54.0m.

In its own words

Electromed, Inc. (“we,” “our,” “us,” “Electromed” or the “Company”) develops, manufactures, markets and sells innovative products that provide airway clearance therapy, including the SmartVest® Airway Clearance System (“SmartVest System”) to patients with compromised pulmonary function with a commitment to excellence and compassionate service. Our goal is to make High Frequency Chest Wall Oscillation (“HFCWO”) treatments as effective, convenient, and comfortable as possible, so our patients can breathe easier and live better with improved respiratory function and fewer exacerbations.

The SmartVest System generates HFCWO, an airway clearance therapy. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective therapy to clear the lung and airway from retained secretions and mucus which can harbor bacteria and lead to infection. One important factor of respiratory health is the ability to clear secretions from airways. Impaired airway clearance, when mucus cannot be expectorated, may result in labored breathing, inflammatory response and/or immune systems boosting mucus production that invites bacteria trapped in stagnant secretions to cause infections.

Quoted from its 10-K, filed 25 Aug 2026. Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
13 Aug 2010
Employees
177
Head office
500 SIXTH AVENUE NW, NEW PRAGUE, MN, 56071
Incorporated in
MN
Classification
Electromedical & Electrotherapeutic Apparatus
Filer status
Non-accelerated filer<br>Smaller reporting company

Leadership

Pay as last reported

  • Ms. Kathleen SkarvanChairman of the Board, since 2012$158,840
  • Mr. James CunniffPresident, Chief Executive Officer, Director, since 2023$1.5m
  • Mr. Bradley NagelChief Financial Officer, Treasurer, Secretary$756,674
  • Ms. Kathleen TuneLead Independent Director$166,840
  • Mr. Stan EricksonIndependent Director$144,340
  • Mr. Gregory FluetIndependent Director$141,340
  • Mr. Joseph GalatowitschIndependent Director$134,340
  • Mr. Andrew SummersIndependent Director$136,340
  • Ms. Andrea WalshIndependent Director$139,340
  • Mr. Mike CavanaughInvestor Relations, since 2022

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
42
Environment
46
Social
49
Governance
32
Carbon reduction policy
No
Human rights policy
No

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Electromed Inc's SmartVest Clearway System uses HFCWO technology for pulmonary care across all age groups.
  • The SmartVest Connect wireless technology offers personalized therapy management for patients with compromised pulmonary function.
  • Electromed's SPU SmartVest and SmartVest Wrap are marketed to healthcare providers in acute care settings.

Weaknesses

  • Electromed Inc has 177 employees, which is a relatively small workforce for a medical equipment company.
  • The company's headquarters in New Prague, Minnesota, may limit access to larger markets.
  • Electromed's IPO in 2010 suggests limited recent capital for expansion.

Opportunities

  • The growing demand for HFCWO technology in pulmonary care presents a significant market opportunity.
  • Expanding the SmartVest Connect app to new regions could increase patient access.
  • Partnerships with healthcare providers in acute care settings could boost sales.

Threats

  • Competition from other medical equipment manufacturers in the Health Care sector.
  • Regulatory changes in the US healthcare market could impact product approvals.
  • Economic downturns may reduce healthcare spending on medical equipment.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.